Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Thespesia populnea extract
- Development stage
- Preclinical
- Administration
- Oral, Topical
01
Overview
Thespesia populnea extract is derived from the Thespesia populnea plant, which is valued for its diverse therapeutic properties. It exhibits anti-inflammatory, antimicrobial, antioxidant, antipsoriatic, antidiarrheal, anticancer, and potential anti-Alzheimer's effects. The extract is rich in bioactive compounds such as flavonoids, sesquiterpenoids, tannins, saponins, and essential oils. It is traditionally used in Ayurvedic medicine for various health conditions and shows potential in wound healing and managing skin diseases.
- Other names
- Thespesia populneaParas-pipalPortia treeIndian Tulip Tree
02
Targets
MAPK3 (Mitogen-activated protein kinase 1)PRKCA (Protein kinase C alpha)PRKCG (Protein kinase C gamma)
Beyond the preview
Go deeper on Thespesia populnea extract.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Thespesia populnea extract.